← graph

manuscript-fig4-flank-pedigree-presentation

Manuscript presentation pass: elevate flank 3D control and right-size pedigree

Metadata

Statusdone
Assignedagent-2542
Agent identity3577bc75d6ed4f1947509aa5c086c91ce7c997c7806dab6bf6affac647452647
Created2026-06-18T11:37:00.287462649+00:00
Started2026-06-18T11:38:22.297699384+00:00
Completed2026-06-18T11:47:26.850711576+00:00
Tagsmanuscript, figures, submission, eval-scheduled
Eval score0.88
└ blocking impact0.95
└ completeness0.84
└ constraint fidelity0.10
└ coordination overhead0.93
└ correctness0.88
└ downstream usability0.88
└ efficiency0.92
└ intent fidelity0.78
└ style adherence0.90

Description

Editing context and objective: The manuscript's central result is the population-scale HPRC v2 sequence discovery: widespread interchromosomal pseudo-homolog regions across 41 of 48 chromosome arms and their arm-level community structure. Assembly-wide quality validation belongs to the accompanying HPRC v2 manuscript and should not be duplicated here. The 3D-genome and pedigree analyses are examinations of whether independent biological observations agree with the sequence-derived picture. Two aspects of the current presentation can lead to avoidable misreadings. First, Figure 4 foregrounds contacts measured within homologous PHR sequence, so a reader may focus on ambiguous mapping and miss the decisive existing control. The chromosome-end pairs identified by PHR homology also show increased contact when contact is measured in adjacent centromere-ward non-PHR flanks. Those flanks do not contain the interchromosomal homology used to define the PHR pairs and can be mapped by Hi-C; therefore, the replicated proximity of those flanks cannot be explained by cross-mapping within the PHRs. The draft already mentions this in the Results and identifies it as the principal control in Methods, but it is visually and rhetorically subordinate to the PHR-internal analysis. Second, the pedigree analysis is not intended as a headline demonstration of individual recombination events. It uses the best available multigenerational T2T pedigree--three generations being necessary to observe transmission--and asks whether its assembly-derived candidate patches are compatible with the independently inferred sequence communities. The draft already labels these as candidates and states that individual events require orthogonal confirmation; this caution should be preserved rather than multiplied. Edit with a light touch so that these points are conveyed mainly through figure emphasis, placement, captions, and precise verb choice--not through new passages explaining the manuscript's evidence hierarchy. Keep the HPRC v2 sequence result as the clear center of gravity. Elevate the existing non-PHR flank result into Figure 4 or its immediate discussion, state the control logic once in a concise sentence, and report its existing effect size or statistic. Do not treat additional mapping simulations or alternative aligners as necessary to rescue the proximity result. Keep the pedigree as the final supportive compatibility analysis; retain the existing candidate language and alter only wording that inadvertently implies event-level validation or makes the pedigree appear co-equal with the population-scale sequence result. Do not add repeated disclaimers, a synthetic "primary versus secondary evidence" paragraph, or broad claim-softening that dilutes the biological model. Make only the associated targeted presentation corrections: clearly distinguish descriptive pointwise correlations from matrix-level inference; remove or visually de-emphasize pointwise P-values where they imply independence among shared PHR and chromosome-arm observations; use one consistent B/W ratio convention; make the mouse labels, aggregation level, and resolution match the analysis while avoiding visual emphasis that suggests a statistically resolved zygotene-specific maximum; and improve Figure 5's legibility without promoting the pedigree analysis into a headline result. Do not invent new analyses, duplicate the HPRC v2 quality-validation manuscript, or rewrite the paper as a defensive response to hypothetical reviewers.

Current context: submission/paper.tex already contains the prior accepted bouquet/de-hedging edits and is the only tracked dirty file relevant to this task. Build with cd submission && guix shell texlive -- make if the default TeX profile is incomplete.

Validation

  • The sequence discovery remains the center of gravity in abstract/results/discussion.
  • Existing adjacent non-PHR flank proximity/control result is elevated into Fig. 4 or the immediate Fig. 4 discussion, with one concise control-logic sentence and the existing effect size/statistic.
  • Pointwise correlations are labeled descriptive where appropriate; matrix-level inference is clearly separate.
  • Pointwise p-values are removed or visually de-emphasized where they imply independent PHR/chromosome-arm observations.
  • B/W ratio convention is used consistently.
  • Mouse labels, aggregation level, and resolution match the analysis and do not imply a statistically resolved zygotene-specific maximum.
  • Figure 5/pedigree wording stays candidate/compatibility-level and does not imply event-level validation.
  • No new analyses, mapping simulations, broad defensive caveats, or HPRC v2 assembly-validation duplication are introduced.
  • Manuscript builds, or any build blocker is recorded precisely.

Depends on

Required by

Log